Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk — Stella

Recruiting

Back to HER2-Positive Breast Carcinoma trials

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Sponsor

Mayo Clinic

Enrollment target

~66 participants

Started

November 2023

Primary completion

December 2026

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov